Ludwig Pierre SchulzeAn “Oprah Moment” for GLP-1 DrugsOprah has ignited a conversation about obesity as a complex disease requiring comprehensive approaches to treatmentApr 8Apr 8
Ludwig Pierre SchulzeHow a Patient Journey Explains the Evolving Landscape of GLP-1 DrugsWe extract lessons from this Q&A for startups operating in the space and others through this deeper lookMar 29Mar 29
Ludwig Pierre SchulzeHow Telehealth Is Breaking BarriersWe delve into the transformative role of telehealth in the modern healthcare landscapeMar 22Mar 22
Ludwig Pierre SchulzeVentures Adding Years of VitalityWe take a look at the fascinating field of longevity tech through the perspective of venture capitalistsMar 15Mar 15
Ludwig Pierre SchulzeThe Impact of GLP-1 DrugsEconomists and investors are weighing in on Ozempic and a new class of weight-loss drugsMar 8Mar 8